Company: VSA
Filing Date: 2025-07-24
Form Type: 6-K
Source: 0001104659-25-070238
Chunk: 1

Company: VisionSys AI Inc
Filing Date: 2025-07-24
Form: 6-K
Chunk 1
---
 Assuming no changes to the Company’s
operations and financing activities the Company estimates that, following the Disposition, its stockholders’ equity as of December
31, 2024 would have increased from approximately negative $247 million to approximately $3.6 million, primarily due to the removal of
the Targets accumulated losses and liabilities from the consolidated balance sheets.

This strategic decision is driven by two key factors:
(i) the need to eliminate underperforming assets, and (ii) the Company’s intention to focus on its future strategic direction, particularly
the expansion into the AI-driven medical software industry. The Targets, which have consistently failed to deliver positive returns, no
longer align with the Company’s long-term vision and core business strengths.

By divesting these non-core operations, the Company
aims to streamline its financial structure, improve overall profitability, and reallocate resources toward high-growth, high-potential
sectors such as AI-powered healthcare solutions — an area that offers significant opportunities for future value creation and sustainable
competitive advantage.

The following diagram illustrates the Company’s corporate structure
following the consummation of the Disposition.

The foregoing description of the is qualified in its entirety by reference
to the full text of the Agreement, which is attached as Exhibit 99.1 to this Form 6-K and are incorporated herein by reference.

Recent Business Development

As previously disclosed,
we have launched our brain machine interaction businesses leveraging the core algorithms and related software and hardware systems (the
“System”) for brain-computer interfaces (“BCI”) through our wholly owned subsidiary, Beijing Wangwen Zhisuan Technology
Co., Ltd.

Our service-based business
model focuses on delivering multimodal BCI signal decoding services in accordance with the client’s technical specifications and
requirements. The scope includes, but is not limited to, system development, testing, optimization, and maintenance. The objective is
to ensure stable BCI system operation tailored to the client’s specific application needs. The primary target clients include internet
technology firms, AI startups, and e-commerce platforms in Asia. As of June 30, 2025, we have generated approximately RMB200,000
in revenue through technical service contracts, with key clients including internet tech companies and AI startups in Asia.

Our product-based business model is to
produce electroencephalography (“EEG”) acquisition devices as well as to provide related technical services. The primary
target clients are medical institutions and research institutions in Asia. As of June 30, 202